Merck Company Description
The new Merck (formerly Schering-Plough) makes medicines for a number of ailments, from stuffy noses and asthma to hypertension and arthritis. The pharmaceutical giant's top prescription drugs include asthma medication Singulair, anti-inflammatory Remicade, hypertension fighters Cozaar and Hyzaar, and cholesterol combatants Vytorin, Zetia, and Zocor. The company also makes animal health pharmaceuticals, as well as childhood and adult vaccines for such diseases as measles, mumps, hepatitis, and shingles. Its OTC drug and personal care offerings include Claritin allergy pills and Dr. Scholl's foot care products. The company completed a reverse merger with the old Merck in 2009 and took on the Merck name.
View the Comprehensive Company Description for Merck
The Company Description provides a historical perspective of Merck's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Merck's evolution in the marketplace.
